Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels

Published:2017-10 Issue:10 Volume:8 Page:e125
ISSN:2155-384X
Container-title:Clinical and Translational Gastroenterology
language:en
Short-container-title:

Author:

Lam Yuk-Fai,Seto Wai-Kay,Wong Danny,Cheung Ka-Shing,Fung James,Mak Lung-Yi,Yuen John,Chong Chun-Kong,Lai Ching-Lung,Yuen Man-Fung

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference24 articles.

1. Chronic hepatitis B virus infection: disease revisit and management recommendations.;Yuen;J Clin Gastroenterol,2016

2. Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment.;Seto;J Gastroenterol Hepatol,2014

3. Long-term entecavir therapy results in the reversal of fibrosiscirrhosis and continued histological improvement in patients with chronic hepatitis B.;Chang;Hepatology,2010

4. Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.;Watanabe;Hepatol Int,2016

5. Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians.;Arends;Gut,2015

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989;Gut;2024-09-12

2. Disease modifiers and novel markers in HBV-related HCC;Journal of Liver Cancer;2024-08-05

3. N-Heterocycles as Promising Antiviral Agents: A Comprehensive Overview;Molecules;2024-05-10

4. Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B;Viruses;2024-03-29

5. Clinical Significance and Remaining Issues of Anti-HBc Antibody and HBV Core-Related Antigen;Diagnostics;2024-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3